In finance, pharmaceuticals, and energy, artificial intelligence now shapes investor analysis, clinical insight, and operational risk modeling. Yet one critical question remains unresolved:
Does the organization know whether its brand, product, or disclosure is visible within the AI-driven discovery pathways that matter?